Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
ÖFOS 2012 - Austrian Fields of Study
- 301904 Cancer research
- 106052 Cell biology
- 301206 Pharmacology
- 304005 Medical biotechnology
- 301902 Immunology
Fingerprint
Dive into the research topics where Andreas Eger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 11 Finished
-
Advanced personalized diagnostics to overcome severe side effects of protein therapeutics
Eger, A. (CoI), Lubich, C. (CoI), Allacher, P. (PI) & Paul, H. (CoI)
Gesellschaft für Forschungsförderung Niederösterreich
24/07/17 → 10/08/23
Project: Research
-
Metabolic plasma profiling of the metabolic syndrome and cancer cachexia
Jacobi, N. (CoI) & Eger, A. (PI)
Gesellschaft für Forschungsförderung Niederösterreich
18/01/16 → 24/03/21
Project: Research
-
DNA methylation in non-small call lung cancer and associated genderspecific influences on therapy efficience
Eger, A. (CoI), Seeböck, R. (PI), Wiesner, C. (CoI) & Hofmann, E. (CoI)
Austrian Research Promotion Agency (FFG)
16/09/15 → 31/07/20
Project: Research
-
Engineering of therapeutic Peptides for cancer and regenerative medicine
Eger, A. (PI), Klein, C. (CoI), Jacobi, N. (CoI) & Hofmann, E. (CoI)
Gesellschaft für Forschungsförderung Niederösterreich
19/01/15 → 29/04/19
Project: Research
-
Establishing molecular toxicology for rapid, early and sensitive toxicity determination and biocompatibility
Hundsberger, H. (PI) & Eger, A. (CoI)
14/02/14 → 7/12/15
Project: Research
-
Concentration-dependent pro-and antitumor activities of quercetin in human melanoma spheroids: Comparative analysis of 2d and 3d cell culture models
Hundsberger, H., Stierschneider, A., Sarne, V., Ripper, D., Schimon, J., WeitzenbÖck, H. P., Schild, D., Jacobi, N., Eger, A., Atzler, J., Klein, C. T. & Wiesner, C., 30 Jan 2021, In: Molecules. 26, 3, 717.Research output: Contribution to journal › Article › peer-review
Open Access -
A Screening Approach for Identifying Gliadin Neutralizing Antibodies on Epithelial Intestinal Caco-2 Cells: SLAS Discovery
Hundsberger, H., Koppensteiner, A., Hofmann, E., Ripper, D., Pflüger, M., Stadlmann, V., Klein, C. T., Kreiseder, B., Katzlinger, M., Eger, A., Forster, F., Missbichler, A. & Wiesner, C., 8 Sept 2017, In: SLAS Discovery. 22, 8, p. 1035-1043 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
ErbB family signalling: A paradigm for oncogene addiction and personalized oncology
Jacobi, N., Seeboeck, R., Hofmann, E. & Eger, A., 12 Apr 2017, In: Cancers. 9, 4, 33.Research output: Contribution to journal › Review article › peer-review
Open Access -
Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: Lessons learned from the inhibition of EGFR signaling
Jacobi, N., Seeboeck, R., Hofmann, E., Schweiger, H., Smolinska, V., Mohr, T., Boyer, A., Sommergruber, W., Lechner, P., Pichler-Huebschmann, C., Onder, K., Hundsberger, H., Wiesner, C. & Eger, A., 8 Dec 2017, In: Oncotarget. 8, 64, p. 107423-107440 18 p.Research output: Contribution to journal › Article › peer-review
Open Access -
The combinatorial approach of lasercaptured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer
Hofmann, E., Seeboeck, R., Jacobi, N., Obrist, P., Huter, S., Klein, C., Önder, K., Wiesner, C., Hundsberger, H. & Eger, A., 7 Apr 2016, In: Biomarker Research. 4, 1, p. 8 8.Research output: Contribution to journal › Article › peer-review
Open Access